References
- Graham DT, Kabler JD, Lunsford L. Vasovagal fainting: a diphasic response. Psychosom Med. 1961;23(6):1–8. doi:10.1097/00006842-196111000-00004.
- Ost LG, Sterner U, Lindahl IL. Physiological responses in blood phobics. Behav Res Ther. 1984;22:109–17. doi:10.1016/0005-7967(84)90099-8.
- Hedberg AG, Schlong A. Eliminating fainting by school children during mass inoculation clinics. Nurs Res. 1973;22:352–53. doi:10.1097/00006199-197307000-00013.
- Fainting after Vaccination. Vaccine Safety | CDC [Internet]. 2020 [cited 2022 Jan 7]. https://www.cdc.gov/vaccinesafety/concerns/fainting.html
- COVID-19 Vaccines. FDA [Internet]. [cited 2022 Jan 7]. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines
- COVID-19: latest updates. European medicines agency [Internet]. [cited 2022 Jan 7]. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates
- Tau N, Yahav D, Shepshelovich D. Vaccine safety - is the SARS-CoV-2 vaccine any different? Hum Vaccines Immunother. 2021;17:1322–25. doi:10.1080/21645515.2020.1829414.
- Centre UM. About VigiBase [Internet]. [cited 2022 Sep 23]. https://who-umc.org/vigibase/
- Chrétien B, Dolladille C, Hamel-Sénécal L, Sassier M, Faillie JL, Miremont-Salamé G, Lelong-Boulouard V, Le Boisselier R, Fedrizzi S, Alexandre J, et al. Comparative study of hypoglycaemia induced by opioids. Is it a class effect? Expert Opin Drug Saf. 2019;18:987–92. doi:10.1080/14740338.2019.1646246.
- Chrétien B, Lelong-Boulouard V, Chantepie S, Sassier M, Bertho M, Brazo P, Humbert X, Alexandre J, Fedrizzi S, Dolladille C. Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase ®. Psychol Med. 2021;51(9):1459–66. doi:10.1017/S0033291720000161.
- WHO. Immunization stress-related response: a manual for program managers and health professionals to prevent, identify and respond to stress-related responses following immunization [Internet]. [cited 2022 Jan 11]. https://www.who.int/publications-detail-redirect/10665330277
- Braun MM, Patriarca PA, Ellenberg SS. Syncope after immunization. Arch Pediatr Adolesc Med. 1997;151:255–59. doi:10.1001/archpedi.1997.02170400041007.
- Bate A, Lindquist M, Edwards IR. The application of knowledge discovery in databases to post-marketing drug safety: example of the WHO database. Fundam Clin Pharmacol. 2008;22:127–40. doi:10.1111/j.1472-8206.2007.00552.x.
- Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet Lond Engl. 2000;356:1255–59. doi:10.1016/S0140-6736(00)02799-9.
- Committee to Review Adverse Effects of Vaccines, Institute of Medicine. Adverse Effects of Vaccines: evidence and Causality [Internet]. Washington (DC): National Academies Press (US); 2011. cited 2022 Jan 11 Available from: http://www.ncbi.nlm.nih.gov/books/NBK190024/.
- Babl FE, Lewena S, Brown L. Vaccination-related adverse events. Pediatr Emerg Care. 2006;22:514–9;quiz 520–2. doi:10.1097/01.pec.0000227874.44878.40.
- Centers for Disease Control and Prevention (CDC). Syncope after vaccination–United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep 2008;57:457–60.
- Crawford NW, Clothier HJ, Elia S, Lazzaro T, Royle J, Buttery JP. Syncope and seizures following human papillomavirus vaccination: a retrospective case series. Med J Aust. 2011;194:16–18. doi:10.5694/j.1326-5377.2011.tb04138.x.
- Hause AM, Gee J, Johnson T, Jazwa A, Marquez P, Miller E, Su J, Shimabukuro TT, Shay DK. Anxiety-Related adverse event clusters after Janssen COVID-19 vaccination - Five U.S. mass vaccination sites, April 2021. MMWR Morb Mortal Wkly Rep. 2021;70:685–88. doi:10.15585/mmwr.mm7018e3.
- Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R, De la Cámara C, Lobo A, Gracia-García P. Prevalence of anxiety in the COVID-19 pandemic: an updated meta-analysis of community-based studies. Prog Neuropsychopharmacol Biol Psychiatry. 2021;109:110207. doi:10.1016/j.pnpbp.2020.110207.
- Faillie J-L. Case-non-case studies: principle, methods, bias and interpretation. Therapie. 2019;74:225–32. doi:10.1016/j.therap.2019.01.006.
- Lin JT, Ziegler DK, Lai CW, Bayer W. Convulsive syncope in blood donors. Ann Neurol. 1982;11:525–28. doi:10.1002/ana.410110513.
- Ministère de la santé. DGS-URGENT. [cited 2022 Feb 3]. https://solidarites-sante.gouv.fr/IMG/pdf/dgs_urgent_44_campagne_az.pdf
- Kuntz JL, Firemark A, Schneider J, Henninger M, Bok K, Naleway A. Development of an Intervention to reduce pain and prevent syncope related to adolescent vaccination. Perm J. 2019;23:17–136. doi:10.7812/TPP/17-136.
- McMurtry CM, Noel M, Taddio A, Antony MM, Asmundson GJG, Riddell RP, Chambers CT, Shah V, HELPinKids&Adults Team. Interventions for individuals with high levels of needle fear: systematic review of randomized controlled trials and quasi-randomized controlled trials. Clin J Pain. 2015;31:S109–123. doi:10.1097/AJP.0000000000000273.
- Kemper AR, Barnett ED, Walter EB, Hornik C, Pierre-Joseph N, Broder KR, Silverstein M, Harrington T. Drinking water to prevent postvaccination presyncope in adolescents: a randomized trial. Pediatrics. 2017;140:e20170508. doi:10.1542/peds.2017-0508.
- Loharikar A, Suragh TA, MacDonald NE, Balakrishnan MR, Benes O, Lamprianou S, Hyde TB, McNeil MM. Anxiety-related adverse events following immunization (AEFI): a systematic review of published clusters of illness. Vaccine. 2018;36:299–305. doi:10.1016/j.vaccine.2017.11.017.
- Montastruc J-L, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72:905–08. doi:10.1111/j.1365-2125.2011.04037.x.
- Common Terminology Criteria for Adverse Events (CTCAE). Protocol Development | CTEP [Internet]. [cited 2022 Sep 23]. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm
- EMA. Good pharmacovigilance practices [Internet]. Eur Med Agency. 2018. cited 2022 Sep 23. Available from: https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/good-pharmacovigilance-practices.
- Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D. Incidence and prognosis of syncope. N Engl J Med. 2002;347:878–85. doi:10.1056/NEJMoa012407.
- Colman N, Nahm K, Ganzeboom KS, Shen WK, Reitsma J, Linzer M, Wieling W, Kaufmann H. Epidemiology of reflex syncope. Clin Auton Res Off J Clin Auton Res Soc. 2004;14(Suppl 1):9–17. doi:10.1007/s10286-004-1003-3.